AngioDynamics ANGO Non-cash lease expense
Non-cash lease expense at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:NoncashLeaseExpense.
The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's non-cash lease expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's non-cash lease expense?
- AngioDynamics (ANGO) reported non-cash lease expense of $489.5K in Q1 2025.
- How has AngioDynamics's non-cash lease expense changed year-over-year?
- AngioDynamics's non-cash lease expense increased by 1.4% year-over-year, from $482.75K to $489.5K.
- What is the long-term trend for AngioDynamics's non-cash lease expense?
- Over 4 years (2021 to 2025), AngioDynamics's non-cash lease expense has grown at a -5.5% compound annual growth rate (CAGR), from $2.46M to $1.96M.
- What does non-cash lease expense mean?
- This represents the non-cash portion of lease expenses recognized in the operating section of the cash flow statement. It reflects the amortization of right-of-use assets and the accretion of lease liabilities that do not impact cash balances. Monitoring this helps analysts distinguish between actual cash outflows for rent and accounting-driven lease expenses.